Viva Ventures Biotech Group
25
9M
18
3.57
11
0.24
3
- Stages of investment
- Areas of investment
Summary
The standard case for the fund is to invest in rounds with more than 10 partakers. Despite the Viva Ventures Biotech Group, startups are often financed by Quark Venture, Polaris Partners, NanoDimension. The meaningful sponsors for the fund in investment in the same round are Total Access Fund, Strawberry Creek Ventures, Polaris Partners.
We can highlight the next thriving fund investment areas, such as Therapeutics, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight SQZ Biotech. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2018.
Investments analytics
Analytics
- Total investments
- 25
- Lead investments
- 11
- Exits
- 3
- Rounds per year
- 3.57
- Follow on index
- 0.24
- Investments by industry
- Biotechnology (15)
- Pharmaceutical (7)
- Health Care (7)
- Medical (5)
- Therapeutics (4) Show 8 more
- Investments by region
-
- United States (15)
- China (4)
- Belgium (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 5
- Avg. valuation at time of investment
- 11M
- Group Appearance index
- 0.80
- Avg. company exit year
- 3
- Avg. multiplicator
- 5.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Anji Pharmaceuticals | 28 Jun 2019 | Pharmaceutical | Early Stage Venture | 14M | United States, Massachusetts, Cambridge |
| Arthrosi Therapeutics | 22 Oct 2021 | Biotechnology, Life Science, Product Research | Late Stage Venture | 14M | United States, California |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.